The applicability of laparoscopic donor nephrectomy (LDN) has not been asse
ssed in the obese donor. We hypothesized that obesity is not a technical co
ntraindication to LDN. From May 1998 to February 1999, 40 patients underwen
t LDN at the Georgetown Transplant Institute with the transperitoneal techn
ique. Prophylaxis against deep venous thrombosis consisted of venous compre
ssion stockings, low-molecular weight heparin in obese patients, and early
ambulation. The following variables were examined: donor sex, age, weight,'
height, related versus nonrelated donation, body mass index (BMI; wt/ht(2))
, operating room time, estimated blood loss, length of stay, time out of wo
rk, and complications. BMI>31 indicates morbid obesity, BRI>27 indicates >2
0% over ideal body weight, and normal BMI is 25. The patients were divided
into nonobese (BMI less than or equal to 31) and obese? groups (BMI>31). Th
e two groups do not differ in outcome after LDN. Our data indicate that obe
sity is not associated with increased morbidity or mortality after LDN.